【新股IPO】貝達藥業通過上市聆訊 集資達78億元 – 香港經濟日報 – 即時新聞頻道 – 即市財經 – 新股IPO 2021-05-30T15:01:00-04:00May 30th, 2021| share this article! A股貝達藥業(深:300558)已通過聯交所上市聆訊,市場消息指,貝達藥業計劃集資多達10億美元(約77.5億港元),高盛、瑞銀及中金為聯席保薦人。貝達藥業指,集資所得的資金計劃用於未來5年在中國及海 Read More share this article! Related Posts IDX-listed laboratory chain Diagnos to buy DNA testing company Asa Ren for $24m April 18th, 2024 India Digest: Trifecta raises $12m debt funding; LightFury Games snags $8.5m seed round April 18th, 2024 IFC mulls $120m debt financing to Bangladeshi apparel maker Epic Group April 18th, 2024 Alibaba’s Taobao launches 3D-capable app for use on Apple’s Vision Pro headset April 18th, 2024